Literature DB >> 7858578

[Bone and joint sites of African histoplasmosis (Histoplasma duboisii). Apropos of a case and review of the literature].

F Simon1, P Y Chouc, V Hervé, D Branquet, P Jeandel.   

Abstract

The authors report a case of disseminated African histoplasmosis with bone and joint involvement in a black 28-year-old citizen of the Central African Republic who presented with a 17-month history of multiple osteoarticular lesions (sternoclavicular joints, humerus, ribs), cutaneous lesions (face, scalp, thorax), and lymphadenopathy. Clinical manifestations resolved rapidly under treatment with ketoconazole (600 mg/d for 10 days then 400 mg/day for nine months). Persistent yeast cells were then found upon examination of a lymph node biopsy specimen. The characteristics and diagnosis of osteoarticular lesions due to African histoplasmosis are discussed on the basis of a review of the literature. Bone and joint lesions due to African histoplasmosis have not yet been reported in patients with the acquired immunodeficiency syndrome. However, the expanding epidemic of human immunodeficiency virus infection in Africa can be expected to result in an increase in the incidence of African histoplasmosis. Imidazole derivatives are easier to use on a long-term basis than amphotericin B and have significantly improved our ability to treat African histoplasmosis.

Entities:  

Mesh:

Year:  1994        PMID: 7858578

Source DB:  PubMed          Journal:  Rev Rhum Ed Fr        ISSN: 1169-8330


  3 in total

1.  Spinal African histoplasmosis simulating tuberculous spondylitis.

Authors:  F Musoke
Journal:  Afr Health Sci       Date:  2001-08       Impact factor: 0.927

2.  Articular presentation of disseminated histoplasmosis.

Authors:  Debajit Sen; Jonathan Birns; Anisur Rahman
Journal:  Clin Rheumatol       Date:  2006-05-25       Impact factor: 2.980

Review 3.  Histoplasmosis in Africa: An emerging or a neglected disease?

Authors:  Rita O Oladele; Olusola O Ayanlowo; Malcolm D Richardson; David W Denning
Journal:  PLoS Negl Trop Dis       Date:  2018-01-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.